🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Journey Medical Corporation

DERM Healthcare
$7.77 $-0.14 (-1.77%)
Market Cap: $219.3 M
Gurus Holding
3
Popularity Rank
#2921
% of Shares Held
0.96%
Net Activity (Q2 2026)
+$203,012

Guru Ownership Trend

Guru Analysis for Journey Medical Corporation (DERM)

Journey Medical Corporation (DERM), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.11 M.

Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.

Institutional sentiment is currently Bullish. This is evidenced by a $203,012 net inflow during the quarter.

Recent activity highlights Cliff Asness who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 5.3%.

Key Holders

Top 5 by Value

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$293,636
Total Buy Value
New Buys 2
Additions 0
-$90,624
Total Sell Value
Reductions 1
Sold Out 0

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
2

FAQs for Journey Medical Corporation (DERM)

Major holders include Renaissance Technologies (RenTech) ($1.63 M), Cliff Asness ($176,129), Jefferies Group ($117,507). According to the latest reported data, 3 tracked investment managers collectively hold approximately 271,174 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $203,012, with 2 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 1 managers trimmed their positions, while 0 fully exited DERM. The total reported sell value was $90,624.

Yes, 2 managers opened new positions in DERM, and 0 increased their existing holdings. The total reported buy value was $293,636.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% Reduce -5.3% 229,700 $1.63 M Q2 2026
0.00% New Buy 24,877 $176,129 Q2 2026
0.00% New Buy 16,597 $117,507 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form